“…The application and limitations of X-ray crystal structure models for structureguided lead discovery (Blundell et al, 2002;Tickle et al, 2004), fragment screening (Burley, 2004;Hartshorn et al, 2005;Fischer & Hubbard, 2009) and drug design (Goodwill, 2001) have been reviewed elsewhere (Davis et al, 2008). As in the case of ordered solvent modelling outlined in x3.1.2, automated programs for ligand placement have been developed and implemented in most crystallographic structuredetermination (Oldfield, 2001;Zwart et al, 2004;Wlodek et al, 2006;Terwilliger et al, 2006Terwilliger et al, , 2007Binkowski et al, 2010;Klei et al, 2014;Echols, Moriarty et al, 2014;Carolan & Lamzin, 2014) and validation (Kleywegt, 2007;Kleywegt & Harris, 2007;Smart et al, 2011;Pozharski et al, 2013;Weichenberger et al, 2013) packages.…”